65,437 trials
Effect of tDCS on Memory in Older and Younger Adults
Primary: Episodic Memory Performance — 0.34; 0.32; 0.46; 0.50 proportion of items
Epithelial Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
Primary: Progression-free Survival (PFS) Differences Between Ixabepilone Alone and Ixabepilone + Bevacizumab — 2.20; 5.46 months — p=<0.001
Atrial Fibrillation
Primary: Number of Participants With Primary Adverse Events (PAEs) — 0; 0; 0 Participants
Acute Myeloid Leukemia With Multilineage Dysplasia · Blasts 20-30 Percent of Bone Marrow Nucleated Cells · Blasts 20-30 Percent of Peripheral Blood White Cells
Primary: Number of Participants With a Response — 11 Participants
Diabetes Mellitus
Primary: Number of Incident Diabetes-related ED Visits and/or Hospitalizations — .88; 1.29 Incidence rate ratio — p=.12
Problem Behavior
Primary: Number of Participants That Completes the Intervention: — 17; 8 Participants
HIV Infections
Primary: Proportion of Participants Who Had Grade 3 or Higher Adverse Event (Cohort 1) — 0 proportion of participants
Rectal Cancer
Primary: Number of Participants Who Completed MSKCC Bowel Function Instrument (BFI Score) in Patients Following Anterior Resection (AR) or Sphincter Preserving Surgery (SPS) for…
Blood Clot · Trauma
Primary: Number of Participants With All-cause Mortality — 45; 47 Participants
Diabetes Mellitus, Type 1
Primary: Treatment-induced Anti-Insulin Antibody (TI-AIA) — 4.8; 42.5 Titers
Type 1 Diabetes Mellitus
Primary: Incidence Rate of Severe Hypoglycemia (Events Per Person Months) — .004 events per person month
Acute Respiratory Failure
Primary: Study Feasibility — 91; 97; 93 Percentage of study days
Post-Operative Atrial Fibrillation
Primary: Percentage of Participants With at Least 1 Continuous AF (Atrial Fibrillation or Atrial Flutter) Episode ≥ 30 Seconds During the First 30 Days Post-surgery — 46.1; 36.5…
Alopecia Areata
Primary: Percentage of Participants Achieving Severity of Alopecia Tool (SALT) ≤ 20 — 2.6; 17.3; 32.5 percentage of participants — p=<0.001
Degenerative Disc Disease
Primary: Transfusion — 7; 6; 9; 8 Participants